Clinical trial
The Role of Microbiome Reprogramming on Liver Fat Accumulation
NCT03914495 is registered in ClinicalTrials.gov with AdventHealth Translational Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Microbiome Reprogramming on Liver Fat Accumulation
- Lead sponsor
- AdventHealth Translational Research Institute
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- May 21, 2019
- Completion date
- June 9, 2021
- Enrollment
- 57 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nafld